Literature DB >> 9052917

Late onset haemolysis and red cell autoimmunisation after allogeneic bone marrow transplant.

F E Chen1, I Owen, D Savage, I Roberts, J Apperley, J M Goldman, M Laffan.   

Abstract

We reviewed the medical records of 293 patients who underwent allogeneic bone marrow transplants at the Hammersmith Hospital between 1989 and 1994. There was clinical evidence of an autoimmune reaction against red cells in nine patients. Seven of these patients had significant haemolysis; the other two had red cell autoagglutination. Haemolysis was resistant to treatment in three cases. Six of the nine patients had monoclonal Ig bands identified within 1 year of transplant. The autoimmune reaction could be classified broadly into two types: an early onset type (n = 4) beginning 2 to 8 months post-transplant associated with a cold antibody, and a late onset type (n = 5) beginning 6 to 18 months post-transplant associated with warm antibodies. The predominant antibody in the two categories described may reflect the kinetics of immune reconstitution post-transplant, since serum IgM levels typically return to normal 2 to 6 months post-transplant, while IgG levels may not reach normal levels until 12-18 months post-transplant. We speculate that unbalanced reconstitution of B and T cell lymphopoiesis post-transplant may favour emergence of oligoclonal proliferation and that some of the resulting antibodies may have activity against red cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9052917     DOI: 10.1038/sj.bmt.1700677

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  19 in total

1.  Anti-CD20 monoclonal antibody therapy for autoimmune hemolytic anemia following T cell-depleted, haplo-identical stem cell transplantation.

Authors:  A Ship; W May; K Lucas
Journal:  Bone Marrow Transplant       Date:  2002-02       Impact factor: 5.483

2.  Diagnosis and management of newly diagnosed childhood autoimmune haemolytic anaemia. Recommendations from the Red Cell Study Group of the Paediatric Haemato-Oncology Italian Association.

Authors:  Saverio Ladogana; Matteo Maruzzi; Piera Samperi; Silverio Perrotta; Giovanni C Del Vecchio; Lucia D Notarangelo; Piero Farruggia; Federico Verzegnassi; Nicoletta Masera; Paola Saracco; Silvia Fasoli; Maurizio Miano; Gabriella Girelli; Wilma Barcellini; Alberto Zanella; Giovanna Russo
Journal:  Blood Transfus       Date:  2016-12-16       Impact factor: 3.443

3.  Posttransplant autoimmune hemolytic anemia and other autoimmune cytopenias are increased in very young infants undergoing unrelated donor umbilical cord blood transplantation.

Authors:  Kristin M Page; Adam M Mendizabal; Vinod K Prasad; Paul L Martin; Suhag Parikh; Susan Wood; Gregory D Sempowski; Paul Szabolcs; Joanne Kurtzberg
Journal:  Biol Blood Marrow Transplant       Date:  2008-10       Impact factor: 5.742

4.  Direct antiglobulin test-negative autoimmune hemolytic anemia associated with HLA-haploidentical stem cell transplantation.

Authors:  Jun Nakata; Hiroya Tamaki; Kazuhiro Ikegame; Ruri Kato; Satoshi Yoshihara; Katsuji Kaida; Takayuki Inoue; Toyomi Kamesaki; Masaya Okada; Hiroyasu Ogawa
Journal:  Int J Hematol       Date:  2011-04-07       Impact factor: 2.490

5.  Rapid Onset Anemia in Chronic Myeloid Leukemia Due to Red Cell Agglutination: A Rare Occurrence.

Authors:  Shikha Garg; Vinod Sharma; Rajive Kumar; Lalit Kumar; Anita Chopra
Journal:  Indian J Hematol Blood Transfus       Date:  2018-03-10       Impact factor: 0.900

6.  Autoimmune hemolysis and immune thrombocytopenic purpura after cord blood transplantation may be life-threatening and warrants early therapy with rituximab.

Authors:  V Bhatt; L Shune; E Lauer; M Lubin; S M Devlin; A Scaradavou; R Parameswaran; M A Perales; D M Ponce; S Mantha; N A Kernan; J N Barker
Journal:  Bone Marrow Transplant       Date:  2016-09-19       Impact factor: 5.483

Review 7.  Immune-Mediated Cytopenias After Hematopoietic Cell Transplantation: Pathophysiology, Clinical Manifestations, Diagnosis, and Treatment Strategies.

Authors:  Thomas F Michniacki; Christen L Ebens; Sung Won Choi
Journal:  Curr Oncol Rep       Date:  2019-08-15       Impact factor: 5.075

8.  The incidence of autoimmune hemolytic anemia in pediatric hematopoietic stem cell recipients post-first and post-second hematopoietic stem cell transplant.

Authors:  Ibrahim Ahmed; Jun Teruya; Cristina Murray-Krezan; Robert Krance
Journal:  Pediatr Transplant       Date:  2015-03-23

Review 9.  A review of transfusion practice before, during, and after hematopoietic progenitor cell transplantation.

Authors:  James L Gajewski; Viviana V Johnson; S Gerald Sandler; Antoine Sayegh; Thomas R Klumpp
Journal:  Blood       Date:  2008-06-26       Impact factor: 22.113

Review 10.  Autoimmune hemolytic anemia.

Authors:  C Hashimoto
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.